3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Rectal Neoplasms
5
Lung Neoplasms
4
Esophageal Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Adenocarcinoma Of Esophagus
4
Colonic Neoplasms
3
Central Nervous System Neoplasms
3
Breast Neoplasms, Male
3
Brain Neoplasms
3
Sarcoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Osteosarcoma
2
Lymphoma
2
Head and Neck Neoplasms
2
Glioblastoma
2
Breast Carcinoma In Situ
2
Vomiting
1
Teratoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Radiation Injuries
1
Peritoneal Neoplasms
1
Oligodendroglioma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm Metastasis
1
Nausea
1
Medulloblastoma
1
Interventions
Radiotherapy, Conformal
2
Ifosfamide
2
Doxorubicin
2
romidepsin
1
indolepropanol phosphate
1
etoposide phosphate
1
Watchful Waiting
1
Vincristine
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Polymerase Chain Reaction
1
Observation
1
Neoadjuvant Therapy
1
Irinotecan
1
HhAntag691
1
Granulocyte Colony-Stimulating Factor
1
Gene Expression Profiling
1
Filgrastim
1
Etoposide
1
Dactinomycin
1
Cyclophosphamide
1
Blotting, Western
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Malignant mesenchymal tumor
×
Chemotherapy, Adjuvant
×
Clear all
No trials found.